How much did ScanSource spend on share repurchases in fiscal 2026?

ScanSource repurchased $97.9 million of common stock during the fiscal year ended June 30, 2026, as disclosed in the Condensed Consolidated Statements of Cash Flows included in the earnings press release.

How many shares were repurchased and at what average price?

The filing does not disclose the number of shares repurchased or the average price paid per share. Only the dollar amount spent ($97.9 million) is provided in the cash flow statement.

What was the execution mechanism for the buyback?

The filing does not specify the execution method—whether the repurchases were made through Rule 10b-18 open-market purchases, an accelerated share repurchase agreement, a 10b5-1 plan, or another mechanism.

Was there a board-authorized repurchase program in place?

The filing does not mention a board authorization, authorization amount, or remaining authorization under any share-repurchase program. The buyback is disclosed only in the cash flow statement without program details.

What impact did the buyback have on EPS?

Weighted-average diluted shares outstanding declined 9.4% year-over-year (from 22.86 million to 20.71 million shares), contributing to a 21.3% increase in diluted EPS (GAAP) from $3.00 to $3.64, even as net income grew 10.2% to $78.9 million.

SCSC 8-K Filed 2026-08-20 Execution disclosure

ScanSource repurchased $97.9M of common stock in fiscal 2026

Company executed $97.9 million in share buybacks during FY2026 amid strong financial results and MicroAge acquisition announcement.

MechanismNot specified

What the filing says

ScanSource, Inc. (NASDAQ: SCSC) repurchased $97.9 million of common stock during fiscal year 2026 ended June 30, 2026, according to the company's earnings press release filed as an 8-K. The buyback activity is documented in the Condensed Consolidated Statements of Cash Flows, where "Common stock repurchased" shows an outflow of $97.9 million for the full fiscal year.

The share repurchase activity occurred during a period of strong operational performance. For fiscal 2026, ScanSource reported net sales of $3.23 billion (up 6.1% year-over-year) and net income of $78.9 million, or $3.64 per diluted share. The company generated $123.1 million in operating cash flow and $113.8 million in free cash flow during the year, reflecting the cash generation available for capital allocation.

The filing does not specify the execution mechanism (e.g., Rule 10b-18 open-market purchases, accelerated share repurchase, or other methods), the average price paid per share, the total number of shares repurchased, nor whether this activity was part of a board-authorized program or remaining authorization amount. The buyback is disclosed only in the cash flow statement line item.

Notably, on the same date as this earnings announcement (August 20, 2026), ScanSource announced an agreement to acquire MicroAge, a leading IT solutions integrator, for $220.5 million in an all-cash transaction expected to close in the quarter ending September 30, 2026.

ScanSource also had share repurchases of $97.9 million for fiscal year 2026. — SCANSOURCE, INC. 8-K filing · View on SEC EDGAR →

What this means

ScanSource allocated $97.9 million to share repurchases during fiscal 2026, representing a continuation of the company's capital return to shareholders. The repurchase contributed to a reduction in weighted-average diluted shares outstanding to 20.71 million for fiscal 2026 from 22.86 million in fiscal 2025—a reduction of approximately 9.4% year-over-year, which accounted for a portion of the company's 21.3% increase in diluted EPS (GAAP basis) despite 10.2% growth in net income. The buyback was executed alongside organic growth investments and acquisitions, indicating the company's ability to execute multiple capital allocation priorities. However, the filing provides no detail on authorization size, program timeline, or execution methodology.

Frequently asked questions

How much did ScanSource spend on share repurchases in fiscal 2026?: ScanSource repurchased $97.9 million of common stock during the fiscal year ended June 30, 2026, as disclosed in the Condensed Consolidated Statements of Cash Flows included in the earnings press release.
How many shares were repurchased and at what average price?: The filing does not disclose the number of shares repurchased or the average price paid per share. Only the dollar amount spent ($97.9 million) is provided in the cash flow statement.
What was the execution mechanism for the buyback?: The filing does not specify the execution method—whether the repurchases were made through Rule 10b-18 open-market purchases, an accelerated share repurchase agreement, a 10b5-1 plan, or another mechanism.
Was there a board-authorized repurchase program in place?: The filing does not mention a board authorization, authorization amount, or remaining authorization under any share-repurchase program. The buyback is disclosed only in the cash flow statement without program details.
What impact did the buyback have on EPS?: Weighted-average diluted shares outstanding declined 9.4% year-over-year (from 22.86 million to 20.71 million shares), contributing to a 21.3% increase in diluted EPS (GAAP) from $3.00 to $3.64, even as net income grew 10.2% to $78.9 million.
Did ScanSource announce any other capital allocation plans?: Concurrent with this earnings announcement, ScanSource announced an agreement to acquire MicroAge for $220.5 million in an all-cash transaction expected to close in Q1 fiscal 2027, indicating the company is balancing share repurchases with M&A investment.

execution technology-sector cash-flow-return fiscal-2026 mid-cap

Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.